CLA (Conjugated Linoleic Acid) for Insulin sensitivity and CLA (Conjugated Linoleic Acid)
Each entry’s own grades, side by side. A grade says how strong the evidence is for one outcome — it does not rank one entry over the other.
Evidence brief
CLA (Conjugated Linoleic Acid) for Insulin sensitivity
Evidence grade C — Possible worsening
Grade C1 graded outcomerevised Jul 10, 2026
Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.
Compound or practice
CLA (Conjugated Linoleic Acid)
A stubborn fat-loss supplement whose human results are trivial — and whose synthetic isomers may worsen metabolic markers.
Grade D2 graded outcomesrevised Jul 10, 2026
A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.
Graded in both
Outcomes are matched by name. Two entries can describe the same outcome in different words, so one listed further down may still be graded in the other.
| Outcome | CLA (Conjugated Linoleic Acid) for Insulin sensitivity | CLA (Conjugated Linoleic Acid) |
|---|---|---|
| Insulin sensitivity | Evidence grade CSmall effectmixedPossible worsening | Evidence grade CSmall effectmixedPossible worsening |
Graded only in CLA (Conjugated Linoleic Acid) for Insulin sensitivity
None — every outcome it grades is graded in both.
Graded only in CLA (Conjugated Linoleic Acid)
- Fat loss Trivial effectEvidence grade D
What each entry says about the other
- CLA (Conjugated Linoleic Acid) for Insulin sensitivity’s entry · Goes with: Read the full CLA (Conjugated Linoleic Acid) monograph
Both columns are read from the entries as they stand in this library. A comparison is not advice to take either one, and it is no substitute for a clinician who knows the person.